Malaysia a good place to set footprints for Indian biotech firms and SMEs
The easy access to South East Asian markets, tax incentives and better infrastructural facilities make Malaysia a good place for the Indian biotech firms including the SMEs to establish their footprints.
India is one of the top five bio tech leaders in the Asia-Pacific region and Malaysia is also undertaking initiatives such as offering 10 year tax holiday, introducing duty exemptions and incentives in order to encourage investments by Indian SMEs in the biotechnology sector.
Indian SMEs should capitalise on the opportunity and look for areas of synergy and untapped areas of Malaysia’s bio technology sector because Malaysia is banking on India to accelerate the development of its bio technology sector.
The Indian SMEs can tap the highly potential Malaysian bio tech market by catering to its numerous sub sectors like bio pharma, vaccines and drugs, bio services, clinical trials, bio-agri, industrial enzymes and bio informatics etc.
The Malaysian and the Indian government are undertaking policy initiatives to promote investments by SMEs from both sides in the bio technology sector.